Oral contraceptives may increase risk for developing gliomas
the ONA take:
According to a new study published in the British Journal of Clinical Pharmacology, researchers have found that certain forms of birth control may increase the risk for developing a glioma, a rare brain cancer.
For the study, researchers analyzed data from Denmark's national registries of health records, cancer cases, and prescriptions in order to identify women aged 15 to 49 years diagnosed with glioma and which women were prescribed contraceptives.
Results showed that women who had used hormonal contraceptives (estrogen, progestin, or both) had a 50% increased risk for developing gliomas compared with those who did not take hormonal contraceptives. In addition, women who used birth control for greater than 5 years had a nearly 200% increased risk for developing gliomas.
Women taking progestin-only contraceptives were at a slightly higher risk for developing the brain cancer than those who took estrogen only or both. The researchers note that although the risk is doubled, the cancer is still rare. Specifically, among Danish women aged 15 to 49 years, only five in 100,000 will develop a glioma.
The results of the study were surprising as previous studies have found that estrogen and progestin may decrease the risk of gliomas, but particularly in post-menopausal women.
Certain forms of birth control may increase the risk for developing a glioma, a rare brain cancer.
Sign Up for Free e-newsletters
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Fosfomycin Effective Alternate for Febrile Neutropenia Prophylaxis
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Breast Implants Associated With Increased Risk of Breast Anaplastic Large-cell Lymphoma
- Survival Outcomes in Relapsed Hepatocellular Carcinoma Improved With Cabozantinib
- OS Similar With Gemcitabine Plus S-1 vs Standard Therapy for Biliary Tract Cancer
- Feasibility and Outcomes of Modified Enhanced Recovery After Surgery for Nursing Management of Aged Patients Undergoing Esophagectomy
- Urine Drug Testing Policy Can Assist Opioid Treatment Decisions
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|